Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events

@article{Coyle2014FinalRF,
  title={Final results from the Betaseron (interferon $\beta$-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events},
  author={P. Coyle and S. Sinclair and A. Scheuerle and J. Thorp and J. Albano and M. Rametta},
  journal={BMJ Open},
  year={2014},
  volume={4}
}
Objective Women with multiple sclerosis are often diagnosed and treated during their reproductive years. Limited data are available on the safety of treatment during pregnancy. The Betaseron Pregnancy Registry prospectively monitored women exposed to interferon β-1b (IFNβ-1b) during pregnancy to estimate the rates of birth defects, spontaneous abortions (SABs) and other negative outcomes in this population. Design From 2006 to 2011, this observational registry enrolled women exposed prior to… Expand
Pregnancy outcomes in patients exposed to interferon beta-1b
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 50 REFERENCES
Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
ACOG Committee Opinion No 579: Definition of term pregnancy.
  • Medicine
  • Obstetrics and gynecology
  • 2013
...
1
2
3
4
5
...